Email not displaying correctly? Click here to view it in your browser.
Therakos and Mallinckrodt

The information in this email is intended only for healthcare professionals in Europe, the Middle East and Asia Pacific.

Registration & Coffee
Jane Apperley, Chair
Department of Haematology and Professor of Haemato-oncology, Faculty of Medicine, Imperial College, London
Session 1: Introduction to Immunomodulation
Improving immunologic outcomes of stem cell transplantation
Krishna Komanduri
Kalish Family Chair in Stem Cell Transplantation, Professor of Medicine, Microbiology & Immunology Director of the Adult Stem Cell Transplant Program, Associate Director for Clinical Innovation, at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami
Session 2: The unmet need of acute GvHD
Making progress in the treatment of acute GvHD
Francis Ayuk
PD Dr. med, Clinic for Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg

Role of intestinal microbiota in GvHD
Marcel van den Brink
Head, Division of Hematologic Oncology; Alan N. Houghton Chair, Memorial Sloan Kettering Cancer Center, New York. Professor of Medicine and Immunology, Weill Cornell Graduate School of Medical Sciences, New York
Coffee break
Session 2: The unmet need of acute GvHD continued
Management of acute GvHD: strategies and clinical outcomes
Francesco Dazzi
Professor of Regenerative and Haematological Medicine, KHP Lead for Cellular Therapies, King’s College London, Visiting Professor at Imperial College, Rayne Institute, London

ECP in acute GvHD
Hildegard Greinix
Univ. Prof. Dr, Head of the Division of Haematology, Medical University of Graz, Graz
Morning Q&A
Session 3: The challenge of chronic GvHD
Identifying patients at risk of developing chronic GvHD and pre-emptive treatment
Andrea Bacigalupo
Professor of Haematology, Director of the Division of Haematology, Foundation Policlinico Universitario A. Gemelli, UniversitĂ  Cattolica del Sacro Cuore, Rome

What is the evidence base for our current chronic GvHD treatments?
Stephanie Lee
Member, Fred Hutchinson Cancer Research Center, Professor, University of Washington, Washington

ECP in chronic GvHD
Hildegard Greinix
Univ. Prof. Dr, Head of the Division of Haematology, Medical University of Graz, Graz
Coffee break
Session 4: UK Photopheresis Society
UK Photopheresis Society – Past, Present and Future
Fiona Dignan
Consultant Haemato-oncologist and Clinical Lead for Haematology, Manchester Royal Infirmary, Manchester

Development of UK Consensus Statement 2017
Arun Alfred
Consultant Haematologist, The Rotherham Foundation Trust, Rotherham
Afternoon Q&A
Reception at venue
This is a commercial programme run by Therakos (UK) Ltd. No registration fees.
Therakos and Mallinckrodt